TRINETRA › Sectors › Chemicals

GSP Crop Science Limited (GSPCROP) — share price, P/E and fundamentals

GSP Crop Science Limited (NSE: GSPCROP) closed at ₹432.90 on 30 Oct 2026, against a 52-week range of ₹328.00 – ₹667.95.

In the quarter ended 30 Jun 2026 (consolidated, filed 11 Aug 2026) it reported revenue of ₹386 cr and net profit of ₹26 cr, a 6.8% net margin.

No trailing P/E is published: only 3 filed quarters available — a trailing twelve months needs 4.

From the balance sheet dated 31 Mar 2026: return on equity 13.7%, ROCE 20.7%, debt-to-equity 0.34.

Against 43 Chemicals peers on NSE: Net margin higher than 36% of 43 sector peers; PBT margin higher than 30% of 43 sector peers; ROE higher than 51% of 41 sector peers.

Key figures

Last close₹432.90 (30 Oct 2026)
Change 1 month / 6 months / 1 year-11.7% / +4.9% / —
52-week low – high₹328.00 – ₹667.95
Market capitalisation₹2,014 cr
Quarter revenue₹386 cr
Quarter net profit₹26 cr
Net margin6.8%
Return on equity13.7%
ROCE20.7%
Debt / equity0.34
Current ratio1.61
Free cash flow₹-18 cr
Average daily turnover (50 days)₹12.2 cr

Against Chemicals peers

MetricGSPCROPPeer medianPercentile
Net margin6.849.9136
PBT margin9.1613.2930
ROE13.6813.6451
ROCE20.7116.0871
Debt / equity0.340.2367
Cash conversion0.630.9538

Questions

What were GSP Crop Science Limited's latest quarterly results?

For the quarter ended 30 Jun 2026, GSP Crop Science Limited reported revenue of ₹386 cr and net profit of ₹26 cr (consolidated), filed with the exchange on 11 Aug 2026.

What is GSP Crop Science Limited's ROE?

Return on equity is 13.7% based on the balance sheet dated 31 Mar 2026.

Does GSP Crop Science Limited have debt?

Debt-to-equity is 0.34 on the balance sheet dated 31 Mar 2026.

What is GSPCROP's 52-week high and low?

Over the last 52 weeks to 30 Oct 2026, GSPCROP traded between ₹328.00 and ₹667.95.

Other Chemicals stocks

Source: consolidated SEBI Integrated Filing for the quarter ended 30 Jun 2026 and NSE daily closes. Open the interactive terminal view for charts and the full statements.

TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing. Figures are as filed with NSE/SEBI and as of the dates shown; they are not live prices.